Registration Rights Agreements in the Pharmaceuticals Industry

670 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (1 contract)
Acacia Diversified Holdings, Inc. (1)
Accelerated Pharma, Inc. (1)
ACELRX PHARMACEUTICALS INC (3)
Acer Therapeutics Inc. (5)
Aclaris Therapeutics, Inc. (3)
Acreage Holdings, Inc. (1)
Adamis Pharmaceuticals Corp (7)
ADIAL PHARMACEUTICALS, INC. (5)
AEOLUS PHARMACEUTICALS, INC. (10)
AEON Biopharma, Inc. (1)
AERIE PHARMACEUTICALS INC (1)
Aerpio Pharmaceuticals, Inc. (5)
AGILE THERAPEUTICS INC (2)
Akers Biosciences, Inc. (2)
Akorn (2)
ALDER BIOPHARMACEUTICALS INC (2)
Alexza Pharmaceuticals Inc. (1)
ALIMERA SCIENCES INC (5)
Allergan, plc (1)
ALSERES PHARMACEUTICALS INC (1)
Altus Pharmaceuticals Inc. (1)
Amag Pharmaceuticals (1)
Amphastar Pharma (1)
Anacor Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (1)
ANI Pharma Inc (1)
Anthera Pharmaceuticals Inc (2)
APP Pharmaceuticals, Inc. (2)
Applied BioSciences Corp. (1)
APRICUS BIOSCIENCES, INC. (10)
Aquestive Therapeutics, Inc. (2)
ARADIGM CORP (4)
Aralez Pharmaceuticals Inc. (9)
ARIAD PHARMACEUTICALS INC (1)
ARTELO BIOSCIENCES, INC. (4)
ARVINAS, INC. (3)
Astex Pharmaceuticals, Inc (4)
AUXILIUM PHARMACEUTICALS INC (1)
AVADEL PHARMACEUTICALS PLC (2)
AVALON PHARMACEUTICALS INC (4)
AVENUE THERAPEUTICS, INC. (4)
AYTU BIOSCIENCE, INC (4)
Baudax Bio, Inc. (1)
Big Rock Partners Acquisition Corp. (8)
BIODELIVERY SCIENCES INTERNATIONAL INC (9)
Biofrontera Inc. (2)
BioNumerik Pharmaceuticals, Inc. (15)
BioPharmX Corp (5)
Blue Water Acquisition Corp. (5)
BODY & MIND INC. (1)
Bohai Pharmaceuticals Group, Inc. (1)
Boston Therapeutics, Inc. (3)
BRADLEY PHARMACEUTICALS INC (2)
Bright Green Corp (2)
Bristol-Myers Squibb (1)
Canbiola, Inc. (4)
Cannabics Pharmaceuticals Inc. (1)
CANNAPHARMARX, INC. (3)
CANNAPOWDER, INC. (1)
Canopy Growth Corp (3)
Cantabio Pharmaceuticals Inc. (1)
CARDAX, INC. (2)
Catalent Inc (4)
Celator Pharmaceuticals Inc (1)
Cerecor Inc. (7)
Cingulate Inc. (1)
Citius Pharmaceuticals, Inc. (4)
Clearside Biomedical, Inc. (1)
Clever Leaves Holdings Inc. (1)
CLS Holdings USA, Inc. (2)
CNS Pharmaceuticals, Inc. (2)
Cocrystal Pharma, Inc. (1)
COGNITION THERAPEUTICS INC (1)
Context Therapeutics Inc. (2)
ContraVir Pharmaceuticals, Inc. (2)
Corcept Therapeutics Incorporated (7)
CorMedix Inc. (5)
Cure Pharmaceutical Holding Corp. (1)
CymaBay Therapeutics, Inc. (1)
Dermata Therapeutics, Inc. (2)
DURECT CORP (1)
Egalet Corp (1)
Elanco Animal Health Inc (2)
ELITE PHARMACEUTICALS INC (4)
Eloxx Pharmaceuticals, Inc. (5)
ENCYSIVE PHARMACEUTICALS INC (2)
Endexx Corp (2)
Endo International plc (46)
EPIX Pharmaceuticals, Inc. (3)
Eton Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (16)
Evolus, Inc. (1)
Exactus, Inc. (3)
EYEGATE PHARMACEUTICALS INC (5)
EYENOVIA, INC. (1)
EyePoint Pharmaceuticals, Inc. (2)
Fulcrum Therapeutics, Inc. (1)
GENAISSANCE PHARMACEUTICALS INC (2)
GRAYBUG VISION, INC. (2)
GREEN HYGIENICS HOLDINGS INC. (3)
GridIron BioNutrients, Inc. (1)
HARROW HEALTH, INC. (2)
Haymaker Acquisition Corp. III (2)
Hoth Therapeutics, Inc. (5)
iANTHUS CAPITAL HOLDINGS, INC. (1)
Ikena Oncology, Inc. (1)
IMAGING3 INC (1)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Innoviva, Inc. (2)
IntelGenx Technologies Corp. (6)
Intersect ENT, Inc. (1)
Intra-Cellular Therapies, Inc. (1)
ISTA PHARMACEUTICALS INC (2)
Item 9 Labs Corp. (1)
Jaguar Health, Inc. (9)
Jazz Pharmaceuticals plc (1)
Jiangbo Pharmaceuticals, Inc. (2)
Johnson & Johnson (1)
JUNIPER PHARMACEUTICALS INC (2)
Kala Pharmaceuticals, Inc. (4)
Kedem Pharmaceuticals Inc. (1)
KEMPHARM, INC (4)
KING PHARMACEUTICALS INC (1)
KOLLTAN PHARMACEUTICALS INC (1)
KOS PHARMACEUTICALS INC (1)
Lev Pharmaceuticals Inc (1)
Level Brands, Inc. (2)
Lexaria Bioscience Corp. (1)
LIPELLA PHARMACEUTICALS INC (1)
Lipocine Inc. (3)
Liquidia Corp (3)
Liquidia Technologies Inc (1)
Lyra Therapeutics, Inc. (2)
MAP Pharmaceuticals, Inc. (1)
Marijuana Co of America, Inc. (1)
MAXIM PHARMACEUTICALS INC (1)
MedGen, Inc. (1)
Menlo Therapeutics Inc. (3)
MICROCHANNEL TECHNOLOGIES CORP (3)
MiddleBrook Pharmaceuticals, Inc. (4)
Milestone Pharmaceuticals Inc. (1)
Mind Medicine (MindMed) Inc. (2)
MIRA PHARMACEUTICALS, INC. (1)
MJ Holdings, Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (2)
MYnd Analytics, Inc. (10)
Nabriva Therapeutics plc (1)
NEKTAR THERAPEUTICS (2)
Neos Therapeutics, Inc. (3)
Neuralstem, Inc. (6)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (2)
Notis Global, Inc. (6)
NovaBay Pharmaceuticals, Inc. (7)
Novan, Inc. (3)
NPS PHARMACEUTICALS INC (2)
NURX PHARMACEUTICALS, INC. (1)
OCULAR THERAPEUTIX, INC (3)
OMEROS CORP (1)
OncoMed Pharmaceuticals Inc (2)
Onconova Therapeutics, Inc. (1)
One World Pharma, Inc. (2)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (1)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (1)
OSCIENT PHARMACEUTICALS CORP (1)
OSI PHARMACEUTICALS INC (2)
Panacea Acquisition Corp (3)
PaxMedica, Inc. (1)
Perrigo (1)
Petros Pharmaceuticals, Inc. (2)
Pharmagreen Biotech Inc. (1)
PHARMOS CORP (5)
Phibro Animal Health Corporation (2)
PLAYERS NETWORK (3)
PLx Pharma Inc. (3)
PREDIX PHARMACEUTICALS HOLDINGS INC (1)
Prestige Brands Holdings Inc (2)
Processa Pharmaceuticals, Inc. (1)
ProPhase Labs, Inc. (2)
PROTECT PHARMACEUTICAL Corp (1)
PROVECTUS BIOPHARMACEUTICALS, INC. (3)
Provention Bio, Inc. (1)
Pulmatrix, Inc. (1)
QUANTA INC (2)
RADIENT PHARMACEUTICALS Corp (4)
Rani Therapeutics Holdings, Inc. (2)
REATA PHARMACEUTICALS INC (1)
Recro Pharma, Inc. (3)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (3)
RespireRx Pharmaceuticals Inc. (2)
resTORbio, Inc. (2)
Rib-X Pharmaceuticals, Inc. (1)
ROCK CREEK PHARMACEUTICALS, INC. (39)
Roivant Sciences Ltd. (1)
Royalty Pharma plc (5)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (1)
Scopus BioPharma Inc. (2)
SCYNEXIS INC (1)
SenesTech, Inc. (1)
Sonoma Pharmaceuticals, Inc. (2)
Synovics Pharmaceuticals (1)
TAPESTRY PHARMACEUTICALS, INC (3)
Targeted Medical Pharma, Inc. (1)
TAURIGA SCIENCES, INC. (4)
Tenzing Acquisition Corp. (4)
Terra Tech Corp. (5)
TETRAPHASE PHARMACEUTICALS INC (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (4)
Textmunication Holdings, Inc. (2)
TFF Pharmaceuticals, Inc. (2)
TherapeuticsMD, Inc. (1)
Theravance Biopharma, Inc. (3)
TITAN PHARMACEUTICALS INC (7)
Tribute Pharmaceuticals Canada Inc. (3)
Trulieve Cannabis Corp. (1)
Urigen Pharmaceuticals, Inc. (6)
Urovant Sciences Ltd. (1)
VASO ACTIVE PHARMACEUTICALS INC (1)
Ventyx Biosciences, Inc. (2)
VIA Pharmaceuticals, Inc. (3)
Vitality Biopharma, Inc. (4)
Winston Pharmaceuticals, Inc. (1)
Xeris Biopharma Holdings, Inc. (1)
Zoetis (3)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Form of Registration Rights Agreement, by and among Aadi Bioscience, Inc. and the purchasers thereto (Aerpio Pharmaceuticals, Inc., Filed With SEC on December 20, 2024)
Form of Registration Rights Agreement, dated November 18, 2024, by and between the Company and the investors named therein (Aclaris Therapeutics, Inc., Filed With SEC on November 18, 2024)
Form of Registration Rights Agreement (Pulmatrix, Inc., Filed With SEC on November 13, 2024)
Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of October 28, 2024 (Evofem Biosciences, Inc., Filed With SEC on October 28, 2024)
Amendment No. 1 to the Registration Rights Agreement, dated as of October 17, 2024, by and among Mind Medicine (MindMed) Inc., Commodore Capital Master LP and Deep Track... (Mind Medicine (MindMed) Inc., Filed With SEC on October 17, 2024)
Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of October 2, 2024 (Evofem Biosciences, Inc., Filed With SEC on October 3, 2024)
Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of September 20, 2024 (Evofem Biosciences, Inc., Filed With SEC on September 25, 2024)
Form of Registration Rights Agreement (Dermata Therapeutics, Inc., Filed With SEC on September 17, 2024)
Registration Rights Agreement by and among Liquidia Corporation and the Purchasers, dated September 10, 2024 (Liquidia Corp, Filed With SEC on September 12, 2024)
Form of Registration Rights Agreement (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on September 6, 2024)
Amendment to Registration Rights Agreement, dated as of April 17, 2024, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP... (Catalent Inc, Filed With SEC on September 6, 2024)
Amended and Restated Registration Rights Agreement, dated as of August 12, 2024 by and between Citius Oncology, Inc. and the signatories thereto (Citius Pharmaceuticals, Inc., Filed With SEC on August 16, 2024)
Form of Registration Rights Agreement to be entered into by and among the Company and the parties signatory thereto (Big Rock Partners Acquisition Corp., Filed With SEC on August 14, 2024)
Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of August 9, 2024 (Evofem Biosciences, Inc., Filed With SEC on August 14, 2024)
Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of July 12, 2024 (Evofem Biosciences, Inc., Filed With SEC on July 23, 2024)
Form of Registration Rights Agreement (ContraVir Pharmaceuticals, Inc., Filed With SEC on July 22, 2024)
Registration Rights Agreement, dated June 26, 2024, by and among KALA BIO, Inc. and the parties thereto (Kala Pharmaceuticals, Inc., Filed With SEC on June 27, 2024)
Form of Registration Rights Agreement (Canopy Growth Corp, Filed With SEC on May 6, 2024)
Form of Registration Rights Agreement (Neuralstem, Inc., Filed With SEC on May 3, 2024)
Registration Rights Agreement (Context Therapeutics Inc., Filed With SEC on May 2, 2024)
Registration Rights Agreement (Cerecor Inc., Filed With SEC on March 28, 2024)
Form of Registration Rights Agreement, dated as of March 7, 2024 between Mind Medicine (MindMed) Inc. and the Investors (Mind Medicine (MindMed) Inc., Filed With SEC on March 11, 2024)
Form of Registration Rights Agreement, dated March 6, 2024, by and among the Company and the Purchasers (Ventyx Biosciences, Inc., Filed With SEC on March 7, 2024)
Registration Rights Agreement, dated February 21, 2024, by and among the Company and the other parties thereto (OCULAR THERAPEUTIX, INC, Filed With SEC on February 22, 2024)
Registration Rights Agreement, dated January 30, 2024, by and between cbdMD, Inc. and the Investor (Level Brands, Inc., Filed With SEC on February 2, 2024)
Form of Registration Rights Agreement by and among CalciMedica, Inc. and the persons party thereto (GRAYBUG VISION, INC., Filed With SEC on January 24, 2024)
Form of Registration Rights Agreement by and among CalciMedica, Inc. and the persons party thereto (GRAYBUG VISION, INC., Filed With SEC on January 22, 2024)
Form of Registration Rights Agreement, dated January 17, 2024, by and among Talphera, Inc. and the Purchasers (ACELRX PHARMACEUTICALS INC, Filed With SEC on January 22, 2024)
Registration Rights Agreement, dated as of January 19, 2024 (Canopy Growth Corp, Filed With SEC on January 19, 2024)
Registration Rights Agreement, dated as of January 4, 2024, by and between Liquidia Corporation and the Purchaser (Liquidia Corp, Filed With SEC on January 8, 2024)
Registration Rights Agreement, dated November 24, 2023, by and among the Company and the other parties thereto (ARVINAS, INC., Filed With SEC on November 27, 2023)
Form of Registration Rights Agreement, dated as of October 27, 2023, by and among VYNE Therapeutics Inc. and the Purchasers (Menlo Therapeutics Inc., Filed With SEC on October 30, 2023)
Form of Registration Rights Agreement (LIPELLA PHARMACEUTICALS INC, Filed With SEC on October 26, 2023)
Form of Registration Rights Agreement, dated October 19, 2023, by and between Adial Pharmaceuticals, Inc. and the Purchaser signatory thereto (ADIAL PHARMACEUTICALS, INC., Filed With SEC on October 24, 2023)
Form of Amended and Restated Registration Rights Agreement (Citius Pharmaceuticals, Inc., Filed With SEC on October 24, 2023)
Form of Registration Rights Agreement (Evofem Biosciences, Inc., Filed With SEC on October 3, 2023)
Registration Rights Agreement, dated September 21, 2023, by and between Oramed Pharmaceuticals Inc. and Scilex Holding Company (ORAMED PHARMACEUTICALS INC., Filed With SEC on September 26, 2023)
Form of Registration Rights Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (TITAN PHARMACEUTICALS INC, Filed With SEC on September 19, 2023)
Form of Registration Rights Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (TITAN PHARMACEUTICALS INC, Filed With SEC on September 18, 2023)
Form of Registration Rights Agreement (Canopy Growth Corp, Filed With SEC on September 18, 2023)